Catherine Skari
-
Jul- 2023 -30 JulyScientific News
Scientists Develop Safer Method for Gene-Editing Therapy Delivery
Researchers have found a new method of delivering gene-editing medicines to persons with blood illnesses such as thalassaemia and sickle…
Read More » -
29 JulyTIF News
NEW SURVEY | Thalassaemia Care Delivery From A Patient Perspective
The survey focuses on capturing the patient perspective on thalassaemia care delivery in various countries. This initiative by TIF aims…
Read More » -
28 JulyScientific News
Deferiprone Reduces Iron Overload in Young Patients With Transfusion-Dependent Beta-Thalassaemia
In young patients with transfusion-dependent beta-thalassaemia (TDT), the use of early-start deferiprone appeared to be well tolerated and was associated…
Read More » -
27 JulyNews
NEWS | WHO Updates Essential Medicines List, Adds New Medicines for Thalassaemia
Until recently, the WHO EML recommended only deferoxamine for iron chelation, limiting patients’ access to other crucial pharmacological alternatives for…
Read More » -
26 JulyNews
CLINICAL TRIALS | Positive Results Found with Transplant for Patients with Aplastic Anemia
The findings were reported in the journal Blood. The trial’s cohort included 35% of patients from underrepresented racial and/or ethnic…
Read More » -
22 JulyScientific News
Epidemiology of Clinically Significant Forms of Alpha- and Beta Thalassemia: A Global Map of Evidence and Gaps
This systematic study looked at the worldwide and birth prevalence of clinically relevant types of alpha- and beta-thalassaemia. Searches were…
Read More » -
19 JulyNews
PUBLICATION | Travel Guidance for Patients and Families
Welcome to ‘Travel Guidance for Patients & Families’, on the newest TIF’s publications! This practical handbook is intended specifically for…
Read More » -
17 JulyNews
CALL TO ALL PATIENTS | Your Voice Matters in Research!
Today, we invite you to be an active participant in ensuring that research that takes place is aligned with your…
Read More » -
10 JulyNews
EHA2023 | Crovalimab Appears Non-inferior to Eculizumab in PNH, Data Shows
At the 2023 EHA Congress, researchers presented data from the ongoing COMMODORE 2 study, which was designed to determine whether…
Read More » -
Jun- 2023 -30 JuneScientific Literature
Nursing Interventions to Improve Quality of Life Among Children and Adolescents with Thalassemia: A Scoping Review
Thalassemia is an inherited blood disorder affecting hemoglobin synthesis which leads to chronic hemolysis that can reduce the quality of…
Read More »
